[Treatment of glaucoma with a pilocarpine-dipivefrin combination (author's transl)].
The author considers that the combined use of pilocarpine and Dipivefrin (Thiloadren) represents an additional effective method of regulating pressure as physiologically as possible in glaucomatous eyes with trophic disorders, thus further reducing the need for surgery. The efficacy of this drop combination is demonstrated with reference to 71 glaucoma patients. The advantages of 0.1% Dipivefrin as compared to 1% epinephrine are pointed out.
D004359:Drug Therapy, Combination; D004837:Epinephrine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D010862:Pilocarpine / Q000627:therapeutic use*
D010862:Pilocarpine; C015173:dipivefrin; D004837:Epinephrine
Glaukomtherapie mit Pilocarpin/Dipivefrin-Kombination.